Cardlytics
CDLX
61 hedge funds and large institutions have $173M invested in Cardlytics in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 14 closing their positions.
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
21% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 14
5% more funds holding
Funds holding: 58 → 61 (+3)
1.88% more ownership
Funds ownership: 5.57% → 7.45% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
42% less capital invested
Capital invested by funds: $299M → $173M (-$126M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1.67M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$12.7M |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
+$8.55M |
| 3 |
Jennison Associates
New York
|
+$7.85M |
| 4 |
JGC
J. Goldman & Co
New York
|
+$3.35M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$3.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$7.52M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$6.92M |
| 3 |
SRFM
Shannon River Fund Management
New York
|
-$3.85M |
| 4 |
NFAM
North Fourth Asset Management
Englewood Cliffs,
New Jersey
|
-$2.61M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.59M |
CDLX Hedge Fund Activity: Q4 2018 in Review
61 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q4 2018, worth a combined $173M — down 42% from $299M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CDLX positions and 14 closed out — a net gain of 3 holders — while 22 added to existing stakes and 13 trimmed.
The largest buyer was Frontier Capital Management, adding an estimated $12.7M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $7.52M sold.
- 61 institutional investors held Cardlytics (CDLX) as of Q4 2018, up from 58 in Q3 2018.
- Funds reported $173M of Cardlytics stock for Q4 2018, down 42% quarter-over-quarter.
- 17 funds opened new Cardlytics positions in Q4 2018 and 14 closed out, a net change of +3 holders.
- The largest Cardlytics buyer in Q4 2018 was Frontier Capital Management, an estimated $12.7M added.
- The largest Cardlytics seller in Q4 2018 was Driehaus Capital Management, an estimated $7.52M sold.
Based on aggregated 13F filings for Q4 2018.